A detailed history of Exane Derivatives transactions in Marathon Oil Corp stock. As of the latest transaction made, Exane Derivatives holds 862 shares of MRO stock, worth $24,610. This represents 0.01% of its overall portfolio holdings.

Number of Shares
862
Previous 27,854 96.91%
Holding current value
$24,610
Previous $699,000 97.28%
% of portfolio
0.01%
Previous 0.22%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$22.02 - $32.17 $594,363 - $868,332
-26,992 Reduced 96.91%
862 $19,000
Q1 2022

Apr 22, 2022

SELL
$16.87 - $26.04 $63,076 - $97,363
-3,739 Reduced 11.83%
27,854 $699,000
Q4 2021

Jan 28, 2022

BUY
$14.24 - $17.26 $449,884 - $545,295
31,593 New
31,593 $518,000
Q4 2018

Jan 31, 2019

SELL
$12.66 - $23.99 $12 - $23
-1 Closed
0 $0
Q3 2018

Oct 24, 2018

SELL
$19.0 - $23.28 $17,290 - $21,184
-910 Reduced 99.89%
1 $0
Q2 2018

Jul 19, 2018

SELL
$15.57 - $21.9 $263,475 - $370,591
-16,922 Reduced 94.89%
911 $0
Q1 2018

Apr 30, 2018

BUY
$14.52 - $19.28 $32,611 - $43,302
2,246 Added 14.41%
17,833 $0
Q4 2017

Jan 29, 2018

BUY
$13.48 - $17.26 $4,920 - $6,299
365 Added 2.4%
15,587 $0
Q3 2017

Oct 18, 2017

BUY
$10.77 - $13.73 $163,940 - $208,998
15,222
15,222 $0

Others Institutions Holding MRO

About MARATHON OIL CORP


  • Ticker MRO
  • Exchange NYSE
  • Sector Energy
  • Industry Oil & Gas E&P
  • Shares Outstandng 677,582,976
  • Market Cap $19.3B
  • Description
  • Marathon Oil Corporation operates as an independent exploration and production company in the United States and internationally. The company engages in the exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas; and the production and marketing of products manufactured from natural gas, such as l...
More about MRO
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.